These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 17353377)

  • 1. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
    Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.
    Fukumoto H; Tennis M; Locascio JJ; Hyman BT; Growdon JH; Irizarry MC
    Arch Neurol; 2003 Jul; 60(7):958-64. PubMed ID: 12873852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
    Gurol ME; Irizarry MC; Smith EE; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon JH; Greenberg SM
    Neurology; 2006 Jan; 66(1):23-9. PubMed ID: 16401840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
    Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
    Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.
    Geda YE; Knopman DS; Mrazek DA; Jicha GA; Smith GE; Negash S; Boeve BF; Ivnik RJ; Petersen RC; Pankratz VS; Rocca WA
    Arch Neurol; 2006 Mar; 63(3):435-40. PubMed ID: 16533972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
    Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
    Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
    Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
    Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.
    Blasko I; Jungwirth S; Jellinger K; Kemmler G; Krampla W; Weissgram S; Wichart I; Tragl KH; Hinterhuber H; Fischer P
    J Psychiatr Res; 2008 Sep; 42(11):946-55. PubMed ID: 18155247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
    Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly.
    Qiu WQ; Sun X; Selkoe DJ; Mwamburi DM; Huang T; Bhadela R; Bergethon P; Scott TM; Summergrad P; Wang L; Rosenberg I; Folstein M
    Int J Geriatr Psychiatry; 2007 Jun; 22(6):536-42. PubMed ID: 17096467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Abeta levels do not reflect brain Abeta levels.
    Freeman SH; Raju S; Hyman BT; Frosch MP; Irizarry MC
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):264-71. PubMed ID: 17413317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
    Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
    Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid beta protein in young and elderly depression: a pilot study.
    Kita Y; Baba H; Maeshima H; Nakano Y; Suzuki T; Arai H
    Psychogeriatrics; 2009 Dec; 9(4):180-5. PubMed ID: 20377819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.
    Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H;
    Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.
    Li G; Sokal I; Quinn JF; Leverenz JB; Brodey M; Schellenberg GD; Kaye JA; Raskind MA; Zhang J; Peskind ER; Montine TJ
    Neurology; 2007 Aug; 69(7):631-9. PubMed ID: 17698783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
    Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
    Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
    Stomrud E; Hansson O; Zetterberg H; Blennow K; Minthon L; Londos E
    Arch Neurol; 2010 Feb; 67(2):217-23. PubMed ID: 20142530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.